3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T79816 | S1P1 agonist 6 | LPL Receptor | |
Compound I (S1P1 agonist 6) is an S1P1 agonist that mitigates autoimmune activity by inhibiting lymphocyte trafficking and has potential as an immunosuppressive agent in autoimmune disease research [1]. | |||
T79817 | S1P1 agonist 6 hemicalcium | LPL Receptor | |
Compound I (S1P1 agonist 6 hemicalcium) is an S1P1 agonist that diminishes autoimmune activity by inhibiting lymphocyte trafficking, and serves as an immunosuppressive agent in researching a range of autoimmune diseases ... | |||
T3258 | Ponesimod | ACT-128800 | S1P Receptor , LPL Receptor |
Ponesimod (ACT-128800) is an orally available sphingosine-1-phosphate receptor 1 (S1PR1, S1P1) agonist with potential immunomodulating activity. |